A Study on Perioperative Endocrine Therapy for Retroperitoneal Laparoscopic Adrenalectomy of Cushing's Syndrome

Xiaobo CUI,Tianyong FAN,Jianwei LI,Zhenmei AN,Lu YANG,Siyuan BU,Qiang WEI

DOI: https://doi.org/10.3969/j.issn.1001-1420.2010.11.008

2010-01-01

Journal of Clinical Urology

Abstract:Objective:To investigate the method and effect of perioperative endocrine therapy for retroperitoneal laparoscopic adrenalectomy of Cushing's syndrome(adrenocortical adenoma).Methods:Clinical laboratory data and outcome of 82 cases of Cushing's syndrome(adrenocortical adenoma) which diagnosed by clinical and pathological method were retrospectively analyzed at west china hospital during 2007-2010.The brief perioperative endocrine therapy recommended that 100 mg hydrocortisone should be given by intravenous injection before and after removal of adrenal adenoma,another 200 mg hydrocortisone given over the first 24 h after operation,then 100 mg Q8 h,100 mg Q12 h,50 mg Q12 h hydrocortisone on next three days thereafter.Oral prednisolone(25 mg) should be used instead of intravenous drug after 3 days,followed by a reduction of 5 mg every 3 days until a maintenance dosage(10 to 15 mg) was reached.Results:All 82 cases were performed the adrenalectomy successfully without any complications.Plasma Cortisol levels were markedly stable on day 1 and day 5,the patient's clinical symptoms improved in hospital while the hormone withdrawal symptoms were not distinct.Conclusions:The treatment can effectively control the occurrence of steroid withdrawal syndrome,and this perioperative endocrine therapy for retroperitoneal laparoscopic adrenalectomy of Cushing's syndrome(adrenocortical adenoma )is a brief and effective method.